Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism

Minerva Endocrinologica

Volumn 38, Issue 3, 2013, Pages 297-304

  Karbek, B ^a   Cakal E ^a   Cakir, E ^a   Bozkurt, N ^a   Unsal I ^a   Sahin M ^a   Delibasi T ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cardiovascular diseases; Insulin resistance; Prediabetic state

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; DIABETIC PATIENT; DISORDERS OF CARBOHYDRATE METABOLISM; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; WAIST HIP RATIO;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, LDL; FASTING; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; PREDIABETIC STATE; RISK FACTORS; SMOKING;

EID: 84890157813     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
2. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000;23:S4-S19.
3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis and classification of diabetes mellitus. Diabetic Med 1998;15:539-53. (Pubitemid 28319935)
4. Zhang L, Qiao Q, Tuomilehto J, Hammar N, Alberti KG, Eliasson M et al. (DECODE study group). Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: the DECODE study. Diabetes Res Clin Pract 2008;82:364-77.
5. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708-23. (Pubitemid 35013848)
6. Faeh D, William J, Yerly P, Paccaud F, Bovet P. Diabetes, pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity. Cardiovasc Diabetol 2007;6:32.
7. Janssen PG, Goiter KJ, Stolk RP, Rutten GE. Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the addition Netherlands study. Prim. Care Diabetes 2007;1:69-74.
8. Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose-a review of diagnosis, clinical implications and management. Diab Vasc Dis Res 2005;2:9-15. (Pubitemid 40333199)
9. Temelkova-Kurktschiev T, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000;23:1830-4.
10. Mitsuhashi N, Onuma T, Kubo S, Takayanagi N, Honda M, Kawamori R. Coronary artery disease and carotid artery intima-media thickness in Japanese type 2 diabetic patients. Diabetes Care 2002;25:1308-12. (Pubitemid 41071137)
11. Shishehbor MH, Bhatt DL, Topol EJ. Using C-reactive protein to assess cardiovascular disease risk. Cleve Clin J Med 2003;70:634-40. (Pubitemid 36939964)
12. Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006;113:1335-62.
13. Biomarkers Definitions Working Group. Biomarkers and surrogate end points: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
14. Ryden L, Standi E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Europ. Heart J 2007;28:88-136.
15. Fonseca V. Risk factors for coronary heart disease in diabetes. Ann Intern Med 2000;133:154-6. (Pubitemid 30490416)
16. Eckel R, Grundy S, Zimmet P. Metabolic syndrome. Lancet 2005;365:1415-28.
17. Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vase Biol 2007;27:15-26. (Pubitemid 46360377)
18. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funag ata Diabetes Study. Diabetes Care 1999;22:920-4. (Pubitemid 29241045)
19. Qiao Q, Hu G, Tuomilehto J, Nakagami T, Balkau B, Borch-Johnsen K et al. Age- and sex-specific prevalence of diabetes and impaired glucoseregu-lation in 1 1 Asian cohorts. Diabetes Care 2003;26:1770-80. (Pubitemid 36929118)
20. The DECODE Study Group. Gender difference in all-cause and cardiovas-cular mortality related to hyperglysemia and newly-diagnosed diabetes. Diabetologia 2003;46:608-17.
21. The DECODE Study Group Consequences of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Diabetes Care 1999;22:1667-71.
22. Nóvoa FJ, Boronat M, Saavedra P, Diaz-Cremades JM, Varillas VF, La Roche F et al. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study. Diabetes Care 2005;28:2388-93. (Pubitemid 41384282)
23. Lin JD, Wan HL, Li JC, Wu CZ, Kuo SW, Hsieh CH et al. Impaired glucose tolerance and impaired fasting glucose share similar underlying pathophysiologies. Tohoku J Exp Med 2007;212:349-57. (Pubitemid 351565832)
24. Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S et al. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the atherosclerosis risk in communities study. Diabetes Care 2007;30:325-31.
25. Festa A, D'Agostino R Jr., Hanley AJ, Karter AJ, Saad MF, Haffner SM. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 2004;53:1549-55. (Pubitemid 38697668)
26. Lim SC, Tai ES, Tan BY, Chew SK, Tan CE. Cardiovascular risk profile in individuals with borderline glycemia. Diabetes Care 2000;23:278-82.
27. Yuan G, Zhou L, Tang J, Yang Y, Gu W, Li F et al. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes Res Clin Pract 2006;72:244-50. (Pubitemid 43744474)
28. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-8.
29. Muntner P, He J, Chen J, Fonseca V, Whelton PK. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the third national health and nutrition examination survey (NHANES III). Ann Epidemiol 2004;14:686-95. (Pubitemid 39233630)
30. Haffner SM. Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol 2003;18:18J-26J, 92.
31. Festa A, Hanley AJ, Tracy RP, D'Agostino R Jr., Haffner SM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 2003;108:1822-30. (Pubitemid 37296091)
32. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708-23. (Pubitemid 35013848)
33. Faeh D, William J, Yerly P, Paccaud F, Bovet P. Diabetes. Pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity. Cardiovasc Diabetol 2007;6:32.
34. Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men. Exp Clin Endocrinol Diabetes 2005;113:334-9. (Pubitemid 40896008)
35. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-406. (Pubitemid 17189260)
36. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87(Suppl. II):II-56-II-65.
37. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7. (Pubitemid 27375333)
38. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study 1987-1993. Am J Epidemiol 1997;146:483-94. (Pubitemid 27391409)
39. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. (Cardiovascular Health Study Collaborative Research Group). Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22. (Pubitemid 29024679)
40. Iglesias del Sol A, Bots ML, Grobbee DE, Hofman A, Witteman JC. Carotid intima-media thickness at different sites: relation to incident myocardial infarction; the Rotterdam Study. Eur Heart J 2002;23:934-40. (Pubitemid 35203871)
41. Rosvall M, Janzon L, Berglund G, Engstrom G, Hedblad B. Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med 2005;257:430-7. (Pubitemid 40604547)
42. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006;37:87-92.